Gotowa bibliografia na temat „Biopsy-based transcriptomics”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Biopsy-based transcriptomics”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Biopsy-based transcriptomics"
Ungar, B., M. Yavzori, E. Fudim, O. Picard, U. Kopylov, R. Eliakim, D. Shouval i in. "P032 Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients". Journal of Crohn's and Colitis 16, Supplement_1 (1.01.2022): i152—i153. http://dx.doi.org/10.1093/ecco-jcc/jjab232.161.
Pełny tekst źródłaDan, S., B. Ungar, S. Ben-Moshe, K. Bahar Halpern, M. Yavzori, E. Fudim, O. Picard i in. "P017 Fecal wash host transcriptomics identifies inflammation throughout the colon and terminal ileum". Journal of Crohn's and Colitis 17, Supplement_1 (30.01.2023): i188. http://dx.doi.org/10.1093/ecco-jcc/jjac190.0147.
Pełny tekst źródłaVoutetakis, Konstantinos, Aristotelis Chatziioannou, Efstathios S. Gonos i Ioannis P. Trougakos. "Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence andIn VivoTissue Ageing". Oxidative Medicine and Cellular Longevity 2015 (2015): 1–17. http://dx.doi.org/10.1155/2015/732914.
Pełny tekst źródłaDinis Fernandes, Catarina, Annekoos Schaap, Joan Kant, Petra van Houdt, Hessel Wijkstra, Elise Bekers, Simon Linder i in. "Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer". Cancers 15, nr 12 (6.06.2023): 3074. http://dx.doi.org/10.3390/cancers15123074.
Pełny tekst źródłaCherry, Hannah, Joe Rastrick, Joanna Jacków, Maddy Parsons i John McGrath. "O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways". British Journal of Dermatology 190, nr 6 (17.05.2024): e78-e79. http://dx.doi.org/10.1093/bjd/ljae105.022.
Pełny tekst źródłaBoldanova, Tuyana, Geoffrey Fucile, Jan Vosshenrich, Aleksei Suslov, Caner Ercan, Mairene Coto-Llerena, Luigi M. Terracciano i in. "Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization". Cell Reports Medicine 2, nr 11 (listopad 2021): 100444. http://dx.doi.org/10.1016/j.xcrm.2021.100444.
Pełny tekst źródłaZhang, Yueyun, Carlos Henrique Venturi Ronchi, Giovanna Ambrosini, Yuanlong Liu, Patrick Aouad, Daria Matvienko, Christoph Merten i Cathrin Brisken. "Abstract PO5-14-06: Transcriptomics-based drug screening in 3D ex vivo patient-drived breast cancer model and patient biopsy for personalized therapy". Cancer Research 84, nr 9_Supplement (2.05.2024): PO5–14–06—PO5–14–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-14-06.
Pełny tekst źródłaCimadamore, Alessia, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli i Rodolfo Montironi. "Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy". Cancers 11, nr 2 (7.02.2019): 196. http://dx.doi.org/10.3390/cancers11020196.
Pełny tekst źródłaDas, Sreyashi, Mohan Kumar Dey, Ram Devireddy i Manas Ranjan Gartia. "Biomarkers in Cancer Detection, Diagnosis, and Prognosis". Sensors 24, nr 1 (20.12.2023): 37. http://dx.doi.org/10.3390/s24010037.
Pełny tekst źródłavan Bergen, Cornelis A. M., Marvyn T. Koning, Edwin Quinten, Agnieszka Mykowiecka, Julieta Sepulveda, Ramin Monajemi, Ruben A. L. De Groen i in. "High-Throughput BCR Sequencing and Single-Cell Transcriptomics Reveal Distinct Transcriptional Profiles Associated with Subclonal Evolution of Follicular Lymphoma". Blood 134, Supplement_1 (13.11.2019): 298. http://dx.doi.org/10.1182/blood-2019-130508.
Pełny tekst źródłaRozprawy doktorskie na temat "Biopsy-based transcriptomics"
Nattes, Tristan de. "Rejet humoral d'allogreffe rénale et allo-immunisation HLA". Electronic Thesis or Diss., Normandie, 2023. http://www.theses.fr/2023NORMR053.
Pełny tekst źródłaKidney transplantation is the best treatment of end-stage renal disease, improving life quality and quantity. Despite advances in pathophysiological knowledge of kidney transplant immunology, kidney transplant rejection remains the major cause of allograft dysfunction, especially antibody-mediated rejection.Antibody-mediated rejection risk assessment is based on the evaluation of donor-specific anti-HLA antibodies. However, these antibodies have a poor predictive value for incidence and prognosis of rejection. This could be explained by the heterogeneity of their intrinsic characteristics. These characteristics depend on cells responsible for their secretion, which include short- and long- lived plasma cells. Consequently, they indirectly depend on the cells responsible for maintaining the pool of these antibody-secreting cells, such as memory B cells. In infectious diseases, it is known that memory B cells are heterogeneous in terms of phenotype, function, degree of clonality, and diversification of their B-cell receptor (BCR). However, this heterogeneity has not been examined in the context of kidney transplantation.The aim of the first part of this thesis was to study the heterogeneity of HLA-specific memory B cells in sensitised patients on kidney transplant waiting list. To this end, single-cell analysis of HLA-specific memory B cells from patients with various aetiologies and degrees of immunisation was performed. This led to their phenotypic and transcriptomic characterisation and to the assessment of their BCR repertoire.The second part of this thesis was dedicated to the diagnosis of kidney transplant rejection.In recent years, biopsy-based transcriptomics has emerged, enabling the assessment of hundreds of transcripts in kidney biopsy tissue. These tools provide the opportunity to elucidate new physiopathological pathways and potentially enhance the diagnosis of rejection, especially humoral rejection. However, their application in clinical practice is still limited due to their restricted availability, required expertise for data processing and interpretation, and cost. Furthermore, their exact impact on patient management remains undetermined. Here, a molecular diagnostic tool with characteristics suitable for clinical use was developed. This tool enables the diagnosis of rejection and its classification between antibody-mediated and T-cell mediated rejection. Subsequently, this tool was assessed in ambiguous clinical situations to evaluate its impact in clinical practice.Through these studies, this thesis focused on enhancing our understanding of the humoral response in renal transplantation, which could help improving immunological risk stratification in transplantation. Additionally, it aimed to improve biopsy-based transcriptomics in the diagnosis of kidney transplant rejection